Skip to main content
. 2019 Nov 11;17(2):449–461. doi: 10.5114/aoms.2019.89677

Figure 4.

Figure 4

Flavopiridol mitigated the CRC malignancy induced by ZIC5. A – MTT assay indicated that flavopiridol restricted CRC cell proliferation induced by ZIC5 overexpression. B – Western blot results also showed the inhibitory effect of ZIC5 on the CDC25C/CDK1/cyclin B1 signaling pathway. C – Scratch assay revealed that flavopiridol inhibited CRC cell migration D – Flavopiridol inhibited ZIC5-overexpressing CRC cell invasion (***p < 0.001)